Africa News Line Friday, 01.23.2026, 8:29 AM
Welcome Guest | RSS
Site menu

Main » 2026 » January » 13

(BUSINESS WIRE)--BitGo Holdings, Inc. (“BitGo”), the digital asset infrastructure company, today announced the launch of its initial public offering of 11,821,595 shares of Class A common stock pursuant to a registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission (the "SEC"). The offering consists of 11,000,000 shares of Class A common stock being offered by BitGo and 821,595 shares of Class A common stock being offered by certain existing stockholders of BitGo. BitGo will not receive any proce ... Read more »

Views: 19 | Added by: africa-live | Date: 01.13.2026 | Comments (0)

INGOLSTADT, Germany - Monday, 12. January 2026 AETOSWire Print



(BUSINESS WIRE) -- SecurityBridge, a leading provider of cybersecurity solutions for SAP, today announced the appointment of Jesper Zerlang as Chief Executive Officer, effective January 1, 2026. Zerlang transitions from his role as Chairman of the Board, a position he has held for the past 12 months, as the company enters its next phase of international expansion, backed by funds advised by BU Bregal Unternehmerkapital (BU).


SecurityBridge protects SAP environments for large enterprises by reducing cyber risk across mission-critical SAP ... Read more »

Views: 18 | Added by: africa-live | Date: 01.13.2026 | Comments (0)

LEXINGTON, Mass. - Monday, 12. January 2026 AETOSWire

Updated national AAC protocol supports hospital-based, fully-reimbursed compassionate access across three solid tumor settings

(BUSINESS WIRE) -- Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that France’s National Agency for Medicines and Health Products Safety (ANSM) has approved an updated national treatment protocol for botensilimab (BOT) plus balstilimab (BAL) under France’s Autorisation d’Accès Compassionnel (AAC) framework.

The updated protocol expands France’s previously granted AAC authorization for BOT+BAL in patients with microsatellite-stable (MSS) metastatic colorectal cancer (mCRC) without active liver metastases to eligible patients with certain ovarian cancers and soft-tissue sarcomas—diseases with substantial unmet medical need after standard options have been exhausted.

The revised protocol is designed to broaden the eligibility criteria, allowin ... Read more »

Views: 14 | Added by: africa-live | Date: 01.13.2026 | Comments (0)

Search

Entries archive

Calendar
«  January 2026  »
Su Mo Tu We Th Fr Sa
    123
45678910
11121314151617
18192021222324
25262728293031